ATE406174T1 - Behandlung von migräne und von gefässerweiterung - Google Patents

Behandlung von migräne und von gefässerweiterung

Info

Publication number
ATE406174T1
ATE406174T1 AT01925666T AT01925666T ATE406174T1 AT E406174 T1 ATE406174 T1 AT E406174T1 AT 01925666 T AT01925666 T AT 01925666T AT 01925666 T AT01925666 T AT 01925666T AT E406174 T1 ATE406174 T1 AT E406174T1
Authority
AT
Austria
Prior art keywords
migraines
vasodilation
treatment
cystatin
relates
Prior art date
Application number
AT01925666T
Other languages
English (en)
Inventor
Philip-John Lamey
Fionnuala Lundy
Christopher Shaw
Original Assignee
Philip-John Lamey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0009125A external-priority patent/GB0009125D0/en
Priority claimed from GB0009123A external-priority patent/GB0009123D0/en
Priority claimed from GB0009127A external-priority patent/GB0009127D0/en
Application filed by Philip-John Lamey filed Critical Philip-John Lamey
Application granted granted Critical
Publication of ATE406174T1 publication Critical patent/ATE406174T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01925666T 2000-04-14 2001-04-17 Behandlung von migräne und von gefässerweiterung ATE406174T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0009125A GB0009125D0 (en) 2000-04-14 2000-04-14 Antagonists
GB0009123A GB0009123D0 (en) 2000-04-14 2000-04-14 Protease inhibitor
GB0009127A GB0009127D0 (en) 2000-04-14 2000-04-14 Vasodilatory agent

Publications (1)

Publication Number Publication Date
ATE406174T1 true ATE406174T1 (de) 2008-09-15

Family

ID=27255667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925666T ATE406174T1 (de) 2000-04-14 2001-04-17 Behandlung von migräne und von gefässerweiterung

Country Status (6)

Country Link
US (1) US7396649B2 (de)
EP (1) EP1272212B1 (de)
AT (1) ATE406174T1 (de)
AU (1) AU5235101A (de)
DE (1) DE60135545D1 (de)
WO (1) WO2001079270A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006064844A1 (ja) 2004-12-16 2006-06-22 Perseus Proteomics Inc. 大腸癌および／または大腸ポリープの診断ならびに術後経過観察および再発のモニター薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ173695A3 (en) 1992-12-30 1996-03-13 George Joe Revis Cystatin containing oral and eatable preparations against dental decay
WO2000008159A2 (en) 1998-08-05 2000-02-17 The University Of British Columbia Production and use of modified cystatins
EP1263955A2 (de) 2000-03-10 2002-12-11 Curagen Corporation Polypeptide und nukleinsäure die dafür kodieren

Also Published As

Publication number Publication date
EP1272212A2 (de) 2003-01-08
US7396649B2 (en) 2008-07-08
US20040092439A1 (en) 2004-05-13
AU5235101A (en) 2001-10-30
WO2001079270A2 (en) 2001-10-25
EP1272212B1 (de) 2008-08-27
WO2001079270A3 (en) 2002-09-06
DE60135545D1 (de) 2008-10-09

Similar Documents

Publication Publication Date Title
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
CY1108563T1 (el) Μεθοδοι και υλικα για τη θεραπεια της ανεπαρκειας (ελλειψης) τεστοστερονης στους ανδρες
TR200102766T2 (tr) Triptaz inhibitörü olarak kullanılan peptidil heterosiklik ketonlar
DE602004013563D1 (de) Rantagonisten
DE69807115D1 (de) Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
WO2003099266A3 (en) Acetamides and benzamides that are useful in treating sexual dysfunction
MXJL03000027A (es) Compuestos de benzimidazol para modular la ige e inhibir la proliferacion celular.
ATE345793T1 (de) Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
DE69919868D1 (de) Oregano zur behandlung interner parasiten und protozoen
IL157457A0 (en) Benzimidazoles that are useful in treating sexual dysfuction
FR2825273B1 (fr) Composition pour le traitement des signes cutanes du vieillissement
ATE406174T1 (de) Behandlung von migräne und von gefässerweiterung
ATE333869T1 (de) Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
WO2003053999A3 (de) Selektive arylguanidinpeptide als urokinaseinhibitoren
EA200301299A1 (ru) Применение ингибиторов il-18 для лечения и предотвращения повреждений цнс
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
ATE318597T1 (de) Candesartan zur behandlung von migräne
DE59813914D1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
DE60229047D1 (de) Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit
DE60136706D1 (de) Ycin-acryloyl derivate und antimetabolische mitteln
DE60005154D1 (de) S-nitrosothiole als agentien zur behandlung von fehlfunktionen des kreislaufs
ATE357441T1 (de) Substituierte 2-pyrrolidin-2-yl-1h-indol- derivative für die behandlung von migräne

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties